|
October, 2005
Serenex Funding / Financing Report
Serenex, Inc. Funding Announcement: October, 2005 Funding Amount: $30 Million Private Placement Preferred Stock Funding Round: Series C Investors: Ritchie Capital, Intersouth Partners, Lilly Ventures, Mediphase Venture Partners, Takeda Research Investment, Seaflower Ventures
Industry: Medical, Oncology Products: Oral Mucositis Technology In-Licensed From Mucosal Therapeutics, LLC, SNX-1012 for Mucositis from Chemotherapy
URL: www.serenex.com
|
|